FDA Approves Novel Gene Therapy for Rare Form of Vision Loss – Medscape
Medscape |
FDA Approves Novel Gene Therapy for Rare Form of Vision Loss
Medscape FDA Approves Novel Gene Therapy for Rare Form of Vision Loss. Marcia Frellick. Disclosures. December 19, 2017. The US Food and Drug Administration (FDA) today approved a new gene therapy to treat a rare form of inherited vision loss that can lead to … |
